首页> 外文期刊>Bioorganic and Medicinal Chemistry >2(S)-(Cycloalk-1-enecarbonyl)-1-(4-phenyl-butanoyl)pyrrolidines and 2(S)-(aroyl)-1-(4-phenylbutanoyl)pyrrolidines as prolyl oligopeptidase inhibitors
【24h】

2(S)-(Cycloalk-1-enecarbonyl)-1-(4-phenyl-butanoyl)pyrrolidines and 2(S)-(aroyl)-1-(4-phenylbutanoyl)pyrrolidines as prolyl oligopeptidase inhibitors

机译:2(S)-(环烷-1-烯羰基)-1-(4-苯基丁酰基)吡咯烷和2(S)-(芳酰基)-1-(4-苯基丁酰基)吡咯烷作为脯氨酰寡肽酶抑制剂

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In order to replace the P2-P1 amide group, different 1-cycloalkenyls and 2-aryls were studied in the place of the P1 pyrrolidine group of a 4-phenylbutanoyl-L-Pro-pyrrolidine structure, which is a well-known prolyl oligopeptidase inhibitor SUAM-1221. The 1-cyclopentenyl and the 2-thienyl groups gave novel compounds, which were equipotent with the corresponding pyrrolidine-analog SUAM-1221. It was shown that the P2-P1 amide group of POP inhibitors can be replaced by an α,β-unsaturated carbonyl group or the aryl conjugated carbonyl group.
机译:为了取代P2-P1酰胺基,研究了不同的1-环烯基和2-芳基代替4-苯基丁酰基-L-Pro-吡咯烷结构的P1吡咯烷基团,该结构是众所周知的脯氨酰寡肽酶抑制剂SUAM-1221。 1-环戊烯基和2-噻吩基基团产生新化合物,其与相应的吡咯烷类似物SUAM-1221等价。结果表明,POP抑制剂的P2-P1酰胺基可以被α,β-不饱和羰基或芳基共轭羰基取代。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号